Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Egnyte and Espero Partner to Deliver Intelligent, AI-Powered Solutions for Clinical Trial Management

MOUNTAIN VIEW, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Egnyte, a leader in secure content collaboration and governance, and Espero, a pioneer in clinical trial eProtocol innovation, today announced a strategic partnership that combines their advanced artificial intelligence (AI) capabilities to revolutionize clinical trial protocol development and management.

This collaboration integrates Egnyte's Content Intelligence Engine and AI Copilot technology with Espero's AI-enabled Insights Driven Protocol Platform to deliver a comprehensive, intelligent solution throughout the clinical trial lifecycle. The integration ensures a single source of truth for all protocol-related documents and streamlines workflows with built-in regulatory features, reducing the risk of inconsistencies or errors when managing multiple systems.

"Partnering with Espero marks a significant milestone in our commitment to innovation that benefits the life sciences sector,” said Abhay Kini, director of Life Sciences at Egnyte. “By combining our powerful content collaboration platform with Espero's groundbreaking eProtocol solutions, we will enable clinical trial organizations to achieve greater efficiency, compliance, and insights, setting a new standard for the future of clinical trial management."

The integrated platform leverages both companies' AI technologies to deliver powerful new capabilities, including:

  • Unified Document Management: The integration will centralize clinical protocols and study documents within Egnyte's secure environment, enhancing collaboration and reducing data silos.
  • Automated Workflows: Document flows between Espero and Egnyte will ensure version control and a clear audit trail while minimizing manual data entry errors.
  • Compliance and Audit Readiness: Egnyte's GxP-compliant environment will ensure adherence to regulatory standards and maintain comprehensive audit trails for enhanced audit readiness.
  • Collaborative Editing and Review: Multiple stakeholders can work on protocol documents simultaneously, benefiting from real-time co-editing and streamlined review processes.
  • Enhanced Security and Access Control: Robust security features protect sensitive clinical data with granular access controls for managing document permissions.
  • Intelligent Content Management: The integration will utilize Egnyte's AI capabilities to organize and retrieve protocol-related content from Espero, facilitating quick access to relevant information.

“We are equipping life sciences organizations with the tools they need to streamline protocol development and enhance data integrity by integrating automation processes and our AI-driven insights with Egnyte's secure content governance,” said Kimberly Tableman, CEO of Espero. “This partnership is another step in our mission to push the boundaries of what’s possible in clinical innovation.”

The solution includes regulatory documentation and submissions, a GxP-compliant environment meeting 21 CFR Part 11 requirements, real-time collaboration with AI-powered insights, intelligent content classification and security controls, and comprehensive audit trails and compliance monitoring.

The Egnyte-Espero integrated solution is available immediately for life sciences organizations looking to modernize their clinical trial processes. For more information about the partnership and its capabilities, visit Egnyte’s booth (#332) at SCOPE 2025 in Orlando, Fla., from February 3 to 6, or the companies’ websites: https://www.egnyte.com/solutions/life-sciences or www.espero-health.com.

Media Contact:
Erin Mancini
Public Relations Manager, Egnyte
media@egnyte.com
(703) 909-0345


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.